DYN peer analysis
Dyne Therapeutics (DYN) against its competitors: price, today's move, 1-year return and market value side by side.
DYN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CAPR Capricor | $8.95 | 4.07% | 42.34% | $518.60M |
| IONS Ionis Pharmaceuticals | $39.20 | 1.03% | -46.82% | $6.67B |
| LRMR Larimar Therapeutics | $2.30 | -0.86% | -39.08% | $286.72M |
| PEPG PepGen | $2.50 | 7.68% | -48.79% | – |
| PTCT PTC Therapeutics | $65.39 | -0.43% | -3.10% | $5.76B |
| SLDB Solid Biosciences | $6.72 | 8.74% | 39.84% | $699.11M |
| SRPT Sarepta Therapeutics | $17.82 | 1.42% | 5.00% | $2.01B |
| STOK Stoke Therapeutics | $27.20 | 4.33% | 2.92% | $1.78B |
| TRDA Entrada Therapeutics | $4.89 | 7.47% | -31.27% | – |
| WVE Wave Life Sciences | $3.34 | 3.73% | -59.86% | $713.97M |
| DYN Dyne Therapeutics | $18.07 | 4.09% | -19.40% | – |
- DYN's peers: CAPR (Capricor), IONS (Ionis Pharmaceuticals), LRMR (Larimar Therapeutics), PEPG (PepGen), PTCT (PTC Therapeutics), SLDB (Solid Biosciences), SRPT (Sarepta Therapeutics), STOK (Stoke Therapeutics).
Updated 2026-11-07 11:53 UTC